The Science

Roseville Center for Interventional Psychiatry

Experience the Future of Mental Health Care

At Roseville Center, we believe in not just treating mental health conditions but empowering individuals to reclaim their lives. Our commitment to cutting-edge therapies is evident in our innovative approach towards managing anxiety, PTSD, and depression. Among our treatment highlights are Ketamine and Spravato, two groundbreaking solutions offering new hope for those struggling with mental health disorders.

Spravato Research Studies

spravato eskatamine at roseville

Spravato Research Studies

Spravato, or esketamine, represents a significant advancement in mental health care, particularly for treatment-resistant depression. As a nasal spray formulation of ketamine, Spravato offers convenience and accessibility without compromising effectiveness. By targeting the NMDA receptor, Spravato rapidly alleviates depressive symptoms and restores hope, paving the way for a brighter future.

Ketamine Research Studies

Many studies about ketamine research have been conducted on the effectiveness of ketamine in treating mental health disorders, such as PTSD, severe anxiety, treatment-resistant depression, and chronic pain.

Regarding mental health, recent research suggests that ketamine therapy could be a valuable tool in the treatment of combat-related PTSD.

Ketamine Research Studies

Ketamine Research Studies
FAQ's

Frequently Asked Questions

These FAQs provide basic information about Roseville Center and treatments offered, but patients should always consult their healthcare provider for personalized advice and guidance.

Ketamine therapy rapidly treats conditions like depression and PTSD by modulating the brain’s glutamate system, promoting synaptic plasticity.

Spravato, a nasal spray derived from Ketamine, offers fast relief for treatment-resistant depression by targeting NMDA receptors, unlike traditional antidepressants.

Yes, when administered by qualified professionals, Ketamine and Spravato are deemed safe and effective, with careful monitoring ensuring patient well-being.

Results vary, but many report rapid improvements in mood and symptom relief within hours or days of treatment, though ongoing therapy may be needed for lasting benefits.

Call Roseville Center to learn more about Spravato.  For additional information about Spravato from Janssen Pharmaceuticals, Inc., the maker of Spravato, visit www.spravato.com.